Lipo-C Fat Blaster
Publiceret forskning og dokumentationsgrundlag
Lipo-C refers to a compounded injectable mixture whose typical constituents are methionine, inositol, choline, L-carnitine and vitamin B12. The published literature addresses these substances individually rather than as a combined injection, and the bulk of that evidence comes from oral supplementation trials and observational nutrition studies. Component-level findings span body-composition meta-analyses for L-carnitine, hepatic steatosis work for choline, insulin-sensitivity and gestational diabetes meta-analyses for myo-inositol, small human studies of dietary methionine restriction, and status and route-of-administration analyses for vitamin B12. Evidence generated for one component under one route and dose does not transfer to a multi-ingredient injectable preparation.
- Lipo-C er en injicerbar blanding af methionin, inositol, cholin, L-carnitin og B12.
- Undersøgelser rapporterer virkninger af individuelle komponenter taget oralt, ikke injektionen.
- Den kombinerede injicerbare formulering er ikke testet i nogen publiceret forsøg.
35 studier · 13 siden 2023 · nyeste 2026
- Undersøgelser citeret
- 35
- Publiceret 2023+
- 13
- Nyeste artikel
- 2026
- Sidst gennemgået
- okt. 2026
Tilbagevendende temaer i litteraturen
- Component-level evidence only; the combined injectable blend was not studied
- L-carnitine and modest changes in body weight, BMI and fat mass in pooled RCT analyses
- Choline availability and hepatic fat accumulation, including reversible steatosis during parenteral nutrition
- Myo-inositol and inositol isomers in insulin resistance, PCOS and gestational diabetes prevention
- Dietary methionine restriction, one-carbon metabolism and intrahepatic lipid content
- Vitamin B12 status in metabolic syndrome and obesity, and comparability of oral, sublingual and intramuscular routes
- Heterogeneity in dose, duration and population across the underlying trials
35 offentliggjorte studier.
Sorteret efter styrken i studiedesignet og derefter efter nyhed. Hver post linker til sin kildepost, så fundet kan kontrolleres mod artiklen i stedet for at tages på vores ord.
- 01Systematisk gennemgang2026
The effect of myo-inositol supplementation on gestational diabetes mellitus prevention: a systematic review and meta-analysis
Poyatos-Leon R, et al. · American Journal of Obstetrics and Gynecology · Myo-inositol; systematic review and meta-analysis of 12 RCTs, 4765 pregnant or preconception women
Pooled data showed a lower incidence of gestational diabetes among women assigned to myo-inositol compared with controls. No significant differences were reported for hypertensive disorders of pregnancy, caesarean delivery, macrosomia, preterm birth or neonatal hypoglycaemia.
- 02Systematisk gennemgang2025
The Effect of the L-Carnitine Supplementation on Obesity Indices: An Umbrella Meta-Analysis
Hamedi-Kalajahi F, et al. · International Journal for Vitamin and Nutrition Research · L-carnitine; umbrella meta-analysis of 8 prior meta-analyses, 16352 participants, 8-30 week interventions at 150-4000 mg/day
The umbrella analysis reported pooled reductions in body weight, BMI and waist circumference across the included meta-analyses. Effect sizes were small and the underlying trials varied widely in dose and duration.
- 03Systematisk gennemgang2025
Vitamin B12, folate, and homocysteine levels in children and adolescents with obesity: a systematic review and meta-analysis
Ulloque-Badaracco JR, et al. · Frontiers in Public Health · Vitamin B12; systematic review and meta-analysis of 20 observational studies, 7791 children and adolescents
No significant difference in vitamin B12 or folate concentrations was found between youth with and without obesity. Homocysteine was significantly higher in the group with obesity.
- 04Systematisk gennemgang2025
Inositol supplementation efficacy in improving key cardiometabolic and anthropometric indices: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Delavar MA, et al. · Diabetology & Metabolic Syndrome · Inositol (predominantly myo-inositol); GRADE-assessed systematic review and meta-analysis of 18 RCTs, n=898
Inositol supplementation was associated with reductions in BMI, waist-to-hip ratio, fasting glucose, insulin, HOMA-IR, triglycerides and blood pressure. The authors applied GRADE and noted variation in certainty across outcomes.
- 05Systematisk gennemgang2025
Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: insights from a systematic review and meta-analysis
Mazur M, et al. · Frontiers in Pharmacology · Vitamin B12; systematic review and meta-analysis of 16 studies, 6098 participants, comparing oral, sublingual and intramuscular routes
All three routes raised serum cobalamin (pooled mean difference +402.6 pg/mL) and lowered homocysteine (pooled mean difference -4.83 umol/L). No statistically significant difference was detected between administration routes for either outcome.
- 06Systematisk gennemgang2024
Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines
Fitz V, et al. · The Journal of Clinical Endocrinology and Metabolism · Myo-inositol and D-chiro-inositol; systematic review and meta-analysis of 30 trials, 2230 participants, conducted to inform international PCOS guidelines
Inositol isomers were associated with metabolic improvements in polycystic ovary syndrome, while metformin performed better on waist-hip ratio and hirsutism. Reproductive outcomes were broadly comparable, with fewer gastrointestinal adverse events reported for myo-inositol.
- 07Systematisk gennemgang2023
Efficacy and safety of carnitine supplementation on NAFLD: a systematic review and meta-analysis
Liu A, et al. · Systematic Reviews · L-carnitine; systematic review and meta-analysis of 8 RCTs in non-alcoholic fatty liver disease
Carnitine supplementation was associated with lower AST and ALT, higher HDL cholesterol and lower triglycerides, with certainty of evidence graded low to moderate. Effects were observed in adult but not younger participant subgroups.
- 08Systematisk gennemgang2023
Vitamin B12, folate, and homocysteine in metabolic syndrome: a systematic review and meta-analysis
Ulloque-Badaracco JR, et al. · Frontiers in Endocrinology · Vitamin B12; systematic review and meta-analysis of 66 articles, 87988 participants
Higher vitamin B12 concentrations were inversely associated with metabolic syndrome (OR 0.87) and higher homocysteine was positively associated (OR 1.19). Folate showed no significant association, and the design was observational rather than interventional.
- 09Systematisk gennemgang2020
Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis
Talenezhad N, et al. · Clinical Nutrition ESPEN · L-carnitine; systematic review and meta-analysis of 37 RCTs, n=2292, with dose-response analysis
Pooled analysis reported reductions in body weight (-1.21 kg), BMI (-0.24 kg/m2) and fat mass (-2.08 kg) relative to control. No significant pooled effect was observed for waist circumference or body fat percentage.
- 10Humant klinisk2025
Eggs, Dietary Choline, and Nonalcoholic Fatty Liver Disease in the Framingham Heart Study
Yiannakou I, et al. · The Journal of Nutrition · Dietary choline; prospective observational cohort analysis, 1414 Framingham Offspring and Third Generation participants, liver fat by CT at baseline and follow-up
Higher dietary choline intake was inversely associated with incident non-alcoholic fatty liver disease (RR 0.69 for the highest versus lowest tertile). Egg intake itself showed no independent association with NAFLD incidence.
- 11Humant klinisk2025
The impact of choline supplementation on oxidative stress and clinical outcomes among patients with non-alcoholic fatty liver disease: a randomized controlled study
Sedhom SS, et al. · Therapeutic Advances in Chronic Disease · Choline (as oral phosphatidylcholine); single-blinded randomised controlled study, 79 NAFLD patients plus 10 healthy volunteers, 2400 mg/day for 12 weeks
The choline arm showed lower controlled attenuation parameter and liver stiffness values, reduced thiobarbituric acid reactive substances and leptin, and improved liver enzymes and triglycerides compared with conventional management. The trial was single-blinded and of modest size.
- 12Humant klinisk2025
Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity.
Antoniotti V, et al. · Diabetes Obes Metab · Myo-inositol (with zinc); double-blind randomised placebo-controlled trial, n=56 adolescents aged 10-18 years with obesity and insulin resistance on a Mediterranean-style isocaloric diet, 3 months
Myo-inositol with zinc improved HDL cholesterol compared with placebo (p = 0.05) but did not improve the primary outcome, HOMA-IR. In a post hoc analysis fasting insulin and HOMA-IR were lower than placebo, mainly in severe obesity, and no adverse events were detected.
- 13Humant klinisk2024
Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial.
Perva IT, et al. · Medicina (Kaunas) · Choline and vitamin B12 (within a multi-nutrient cocktail); randomised double-blind placebo-controlled pilot trial, n=155 adults with metabolic syndrome, obesity and steatotic liver disease, three months
The cocktail (5-MTHF, betaine, alpha-linolenic acid, EPA, DHA, choline bitartrate and vitamin B12) reduced controlled attenuation parameter by 4% and transient elastography by 7.8% compared with placebo. The contributions of choline and vitamin B12 cannot be separated from the other components.
- 14Humant klinisk2022
The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Talari HR, et al. · Sci Rep · Vitamin B12 (oral cyanocobalamin); double-blind placebo-controlled randomised trial, forty patients with non-alcoholic fatty liver disease, 12 weeks
Vitamin B12 lowered homocysteine compared with placebo (P = 0.038), but changes in liver enzymes, fasting glucose, malondialdehyde and liver steatosis grade did not differ significantly between groups.
- 15Humant klinisk2021
Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight/obese women with polycystic ovary syndrome: A randomized controlled trial.
Sangouni AA, et al. · Clin Nutr ESPEN · L-carnitine; double-blind randomised placebo-controlled trial, sixty-two overweight or obese women with polycystic ovary syndrome, 12 weeks
L-carnitine had no significant effect on lipid accumulation product, atherogenic index of plasma, atherogenic coefficient or Castelli II index compared with placebo. The authors concluded there was no beneficial effect on liver fat content, which was assessed through these calculated indices.
- 16Humant klinisk2021
Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial.
Saneian H, et al. · J Pediatr Endocrinol Metab · L-carnitine; randomised triple-blind placebo-controlled trial, children and adolescents aged 5-15 years with non-alcoholic fatty liver disease, three months, 55 completers
L-carnitine did not change liver enzymes, anthropometric measures or ultrasound grade of fatty liver compared with placebo. Both groups received lifestyle advice, and liver enzymes improved within both groups.
- 17Humant klinisk2021
Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial.
Wilcox J, et al. · Am J Med · Choline (as choline bitartrate supplements); randomised clinical trial, healthy volunteers with normal renal function (median age 28) in five arms including choline bitartrate, eggs and phosphatidylcholine, 4 weeks
Plasma TMAO and platelet reactivity rose significantly in all three arms containing choline bitartrate, but not with whole eggs or phosphatidylcholine supplements. TMAO is a gut-microbe-derived prothrombotic and proatherogenic metabolite; clinical events were not measured.
Rapporteret sikkerhedsfund. Choline bitartrate supplements raised plasma TMAO and platelet reactivity in healthy volunteers.
- 18Humant klinisk2020
B-vitamins and body composition: integrating observational and experimental evidence from the B-PROOF study.
Oliai Araghi S, et al. · Eur J Nutr · Vitamin B12 (with folic acid); double-blind randomised placebo-controlled trial (B-PROOF), n=2919 adults aged 65 or older with elevated homocysteine, 2 years, body composition by DXA
Random allocation to folic acid plus vitamin B12 did not change BMI, fat mass index or fat-free mass index over 2 years compared with placebo. Cross-sectional associations between B-vitamin status and body composition in the same participants were not confirmed by the randomised comparison.
- 19Humant klinisk2019
l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
Koeth RA, et al. · J Clin Invest · L-carnitine; clinical study with oral isotope-labelled L-carnitine challenges before and after antibiotics and after at least 2 months of L-carnitine supplementation, in omnivores (n=40) and vegans/vegetarians (n=32)
Gut microbes converted oral L-carnitine to gamma-butyrobetaine and then to TMA and TMAO, with more than 20-fold greater labelled TMAO generation in omnivores than in vegans/vegetarians. Chronic L-carnitine supplementation induced the microbial step to TMA; TMAO is a metabolite linked to atherosclerosis and thrombosis, and clinical events were not measured.
Rapporteret sikkerhedsfund. Chronic L-carnitine supplementation induced gut microbial production of TMAO, a pro-atherogenic and pro-thrombotic metabolite.
- 20Humant klinisk2013
Skeletal muscle carnitine loading increases energy expenditure, modulates fuel metabolism gene networks and prevents body fat accumulation in humans.
Stephens FB, et al. · J Physiol · L-carnitine (with carbohydrate); randomised controlled trial, n=12 healthy men, L-carnitine plus carbohydrate versus carbohydrate alone, 12 weeks
Body mass and whole-body fat mass rose by 1.9 and 1.8 kg with carbohydrate alone but did not change with added L-carnitine, which increased muscle total carnitine by 20% and energy expenditure by 6%. The study was small and tested prevention of fat gain during carbohydrate feeding rather than fat loss.
- 21Humant klinisk2012
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome.
Santamaria A, et al. · Climacteric · Myo-inositol; randomised placebo-controlled trial, eighty postmenopausal women with metabolic syndrome on a low-energy diet, 12 months
Myo-inositol improved glucose, insulin, HOMA-IR, triglycerides, cholesterol and blood pressure compared with placebo, but BMI and waist circumference did not differ between groups. Eight women (20%) on myo-inositol and one on placebo no longer met metabolic syndrome criteria.
- 22Humant klinisk2011
Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome
Plaisance EP, et al. · The Journal of Clinical Endocrinology and Metabolism · Methionine; randomised proof-of-concept trial, 26 obese adults with metabolic syndrome, methionine-restricted diet versus methionine-replete control for 16 weeks
Methionine restriction was associated with an increase in fat oxidation and a reduction in intrahepatic lipid content, measured independently of weight loss. The study was small and examined dietary restriction of methionine rather than methionine administration.
- 23Humant klinisk2010
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients.
Derosa G, et al. · Endocr J · L-carnitine (added to orlistat); randomised trial, two hundred and fifty-eight adults with uncontrolled type 2 diabetes, orlistat plus L-carnitine versus orlistat alone, 12 months
Body weight, HbA1c, fasting and post-prandial glucose, LDL cholesterol and HOMA-IR fell faster and further with orlistat plus L-carnitine than with orlistat alone, and no significant adverse events were recorded. There was no L-carnitine-only or placebo arm, and blinding is not described in the abstract.
- 24Humant klinisk2010
L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial.
Malaguarnera M, et al. · Am J Gastroenterol · L-carnitine; randomised controlled trial, patients with non-alcoholic steatohepatitis, L-carnitine plus diet versus diet alone, 24 weeks
L-carnitine with diet improved liver enzymes, lipids, glucose, HOMA-IR, CRP, TNF-alpha and histological scores more than diet alone. Participant numbers are not given in the abstract and the control group received diet alone without placebo.
- 25Humant klinisk2007
Sex and menopausal status influence human dietary requirements for the nutrient choline
Fischer LM, et al. · The American Journal of Clinical Nutrition · Choline; controlled inpatient depletion-repletion study, 57 adults, 10 days adequate choline then up to 42 days of a choline-deficient diet
Fatty liver or muscle damage developed in 77% of men and 80% of postmenopausal women during choline deprivation, compared with 44% of premenopausal women. Some men developed organ dysfunction while consuming intakes at the then-current recommended level.
- 26Humant klinisk2007
L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial.
Malaguarnera M, et al. · Am J Clin Nutr · L-carnitine (levocarnitine); randomised double-blind placebo-controlled trial, sixty-six centenarians with fatigue (32 levocarnitine, 34 placebo)
Compared with placebo, levocarnitine reduced total fat mass (-1.80 versus 0.6 kg) and increased total muscle mass (3.80 versus 0.8 kg), with improvements in physical and mental fatigue and Mini-Mental State Examination scores. The population was centenarians and the abstract does not state the study length.
- 27Humant klinisk2006
Carnitine does not improve weight loss outcomes in valproate-treated bipolar patients consuming an energy-restricted, low-fat diet.
Elmslie JL, et al. · Bipolar Disord · L-carnitine; randomised placebo-controlled trial, sixty bipolar patients with valproate-related weight gain on an energy-restricted low-fat diet, 26 weeks
L-carnitine did not improve weight loss compared with placebo (-1.9 kg versus -0.9 kg, p = 0.381), and the number of patients losing any weight was identical. More patients on carnitine lost at least 5% of body weight (nine versus five), but the difference was not significant.
- 28Humant klinisk2003
Carnitine and choline supplementation with exercise alter carnitine profiles, biochemical markers of fat metabolism and serum leptin concentration in healthy women.
Hongu N, Sachan DS · J Nutr · L-carnitine and choline; randomised placebo-controlled trial, nineteen healthy women, choline, carnitine or placebo preloading followed by choline plus carnitine with mild exercise over 3 weeks
Choline alone lowered serum and urinary carnitine, which carnitine restored, and the supplements raised serum beta-hydroxybutyrate and acetylcarnitine, which the authors interpreted as greater fat mobilisation and incomplete fatty-acid oxidation. Body weight and fat mass outcomes are not reported in the abstract.
- 29Humant klinisk2001
Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial.
Buchman AL, et al. · JPEN J Parenter Enteral Nutr · Choline (intravenous choline chloride in parenteral nutrition); randomised placebo-controlled trial, fifteen long-term home parenteral nutrition patients (7 choline, 8 usual parenteral nutrition), 24 weeks with follow-up to week 34
Choline-supplemented parenteral nutrition raised liver CT density (indicating less hepatic fat) from week 4 and lowered ALT compared with usual parenteral nutrition, and steatosis recurred 10 weeks after choline was stopped. The population had parenteral-nutrition-associated choline deficiency.
- 30Humant klinisk2000
L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women.
Villani RG, et al. · Int J Sport Nutr Exerc Metab · L-carnitine; randomised double-blind placebo-controlled trial, n=36 moderately overweight premenopausal women in a walking programme, 8 weeks
L-carnitine did not change total body mass, fat mass or resting lipid utilisation compared with placebo among completers (13 L-carnitine, 15 placebo). Five women in the L-carnitine group withdrew because of nausea or diarrhoea.
Rapporteret sikkerhedsfund. Five of 18 women assigned L-carnitine withdrew because of nausea or diarrhoea.
- 31Humant klinisk1998
Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults.
Bellamy MF, et al. · Circulation · Methionine; randomised crossover study, n=24 healthy volunteers, single oral methionine load versus control day
Plasma homocysteine rose to 23.1 micromol/L at 4 hours after oral methionine (P<0.0001), and flow-mediated brachial artery dilatation fell from 0.12 to 0.06 mm. The impairment of endothelial function tracked the rise in homocysteine.
Rapporteret sikkerhedsfund. An oral methionine load acutely raised homocysteine and impaired endothelium-dependent vasodilatation in healthy adults.
- 32Humant klinisk1995
Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation
Buchman AL, et al. · Hepatology · Choline; open interventional case series, 4 long-term total parenteral nutrition patients, 1-4 g/day intravenous choline for 6 weeks
Plasma free choline normalised within one week and hepatic steatosis resolved on computed tomography, with liver density rising from -14.2 to 13.1 Hounsfield units. Steatosis recurred after choline was withdrawn.
- 33Gennemgang2026
Methionine restriction and mimetics to ameliorate human aging and disease
Parkhitko AA, et al. · Trends in Endocrinology and Metabolism · Methionine and one-carbon metabolism; narrative review of cross-species and early clinical evidence
The review summarised evidence that methionine restriction altered metabolic and ageing-related endpoints across species and outlined mimetic strategies in early-stage clinical evaluation. Reported obstacles included palatability, tolerability, microbiota-driven methionine supply and compensatory cysteine effects.
- 34Caserapport2018
Acneiform eruptions caused by vitamin B12: A report of five cases and review of the literature.
Veraldi S, et al. · J Cosmet Dermatol · Vitamin B12 (intramuscular or oral); case series of five women aged 21 to 62 years with acneiform eruptions
Papulopustular facial eruptions, in three patients extending to the neck, shoulders, chest and upper back, appeared from 1 week to 5 months after starting intramuscular or oral vitamin B12. All five remitted completely 3-6 weeks after vitamin B12 was stopped, and two had very high serum B12 levels.
Rapporteret sikkerhedsfund. Vitamin B12 given intramuscularly or orally was followed by acneiform eruptions that resolved after discontinuation.
- 35Caserapport1983
Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.
Schaumburg H, et al. · N Engl J Med · Vitamin B6 (pyridoxine); case series of seven adults with long-term high-level pyridoxine consumption
All seven developed ataxia and severe sensory nervous-system dysfunction, and four were severely disabled; all improved after pyridoxine was withdrawn. Weakness was not a feature and the central nervous system was clinically spared.
Rapporteret sikkerhedsfund. High-level pyridoxine intake caused sensory neuropathy or neuronopathy, severely disabling in four of seven patients.
Hvad denne evidens ikke fastslår.
The combined injectable lipotropic formulation containing methionine, inositol, choline, L-carnitine and vitamin B12 has not been evaluated in any controlled trial; no published study has assessed the mixture's pharmacokinetics, additive or interactive effects, or clinical endpoints. Nearly all the available data come from oral supplementation or dietary-intake studies of single components in specific populations, so extrapolation to an injected multi-ingredient product is not supported.
Almindelige spørgsmål om forskningen.
- What is Lipo-C?
Lipo-C is a ready-mixed 10 ml research solution combining L-carnitine with the classical lipotropic factors (methionine, inositol, choline), vitamins B12 and B6, and NADH. It is supplied for laboratory research into lipotropic and mitochondrial fatty-acid-transport pathways.
- What is a "lipotropic" compound?
In the nutrition literature, lipotropic factors are compounds — classically methionine, inositol, and choline — involved in hepatic phospholipid synthesis and the export of lipid from the liver. The cited reviews describe this biochemistry for the individual constituents.
- Has the combined formulation been studied in trials?
No. The peer-reviewed literature cited on this page concerns the individual constituents; the combined formulation has not been the subject of controlled trials, and no conclusions about the mixture should be drawn from single-compound research.
- What does the research on L-carnitine show?
The largest syntheses concern oral L-carnitine supplementation rather than injection. A 2020 systematic review and meta-analysis of 37 randomised trials in 2,292 participants reported pooled reductions in body weight of 1.21 kg, BMI of 0.24 kg/m2 and fat mass of 2.08 kg, with no significant pooled effect on waist circumference or body fat percentage. A 2025 umbrella analysis of eight prior meta-analyses covering 16,352 participants reported the same direction of effect with small effect sizes and wide variation in dose and duration across the underlying trials.
Fås i vores katalog
Kun til forskningsformål. Ikke til humant forbrug, diagnose, behandling eller forebyggelse af nogen tilstand. Intet på denne side er medicinsk rådgivning, og intet studie opsummeret her skal læses som en anbefaling.